Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale President sold 15,000 shares at an average $62.29 ($934,365)
  2. 4 Open-market sale President sold 30,000 shares at an average $61.49 ($1,844,636)
  3. 4 Grant or award Director acquired 1,504 shares (grant or award)
  4. 4 Grant or award Director acquired 1,504 shares (grant or award)
  5. 4 Open-market sale Chief People Officer sold 2,000 shares at $65.45 ($130,900)
  6. 4 Open-market sale President sold 30,000 shares at an average $65.61 ($1,968,432)
  7. 4 Open-market sale SVP and General Counsel sold 16,250 shares at an average $64.64 ($1,050,327)
  8. 4 Open-market sale Chief Business Development Off sold 16,250 shares at an average $64.64 ($1,050,381)
  9. 4 Grant or award Director acquired 1,504 shares (grant or award)
  10. 4 Open-market sale Director sold 2,000 shares at $65.45 ($130,900)
  11. 4 Grant or award Director acquired 1,504 shares (grant or award)
  12. 4 Grant or award Director acquired 1,504 shares (grant or award)
  13. 4 Open-market sale Director sold 6,000 shares at $65.08 ($390,480)
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 4 Open-market sale President sold 30,000 shares at an average $63.12 ($1,893,554)
  17. 4 Open-market sale CEO and Chairman sold 30,000 shares at an average $62.31 ($1,869,322)
  18. 4 Open-market sale President sold 30,000 shares at an average $62.25 ($1,867,532)
  19. SC 13G Stake Amended Statement of Ownership
  20. 4 Open-market sale President sold 15,000 shares at an average $59.96 ($899,328)

Page 26 of 42 · 837 filings